Clinical Trial

A Phase III Study of SYHA1813 for Recurrent or Progressive High-Grade Meningiomas

Name: A Phase III Study of SYHA1813 for Recurrent or Progressive High-Grade Meningiomas — clinical trial record (NCT07613450)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a randomized, controlled, open-label, multicenter, Phase III clinical study designed to compare the efficacy and safety of SYHA1813 versus treatment of investigators' choice in patients with recurrent or progressive high-grade meningioma not amenable to local therapy.

Trial Details

NCT Number	NCT07613450
Lead Sponsor	Shanghai Runshi Pharmaceutical Technology Co., Ltd
Conditions	High Grade Meningioma
Enrollment	136 participants
Start Date	2026-05-20
Primary Completion	2029-07-31 (estimated)
Study Completion	2029-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-29